The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Two-color analysis of the expression of CD19 on mouse spleen B cells. BALB/c splenocytes were simultaneously stained with PE-conjugated mouse anti-mouse IgM[a] mAb DS-1 (Cat. No. 553517) and either purified rat IgG2a, κ isotype control mAb R35-95 (Cat. No. 553927, left panel) or purified rat anti-mouse CD19 mAb 1D3 (right panel). The staining of primary antibody was detected with FITC-conjugated goat anti-rat Ig (Cat. No. 554016). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Two-color analysis of the expression of CD19 on mouse spleen B cells. BALB/c splenocytes were simultaneously stained with PE-conjugated mouse anti-mouse IgM[a] mAb DS-1 (Cat. No. 553517) and either purified rat IgG2a, κ isotype control mAb R35-95 (Cat. No. 553927, left panel) or purified rat anti-mouse CD19 mAb 1D3 (right panel). The staining of primary antibody was detected with FITC-conjugated goat anti-rat Ig (Cat. No. 554016). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Two-color analysis of the expression of CD19 on mouse spleen B cells. BALB/c splenocytes were simultaneously stained with PE-conjugated mouse anti-mouse IgM[a] mAb DS-1 (Cat. No. 553517) and either purified rat IgG2a, κ isotype control mAb R35-95 (Cat. No. 553927, left panel) or purified rat anti-mouse CD19 mAb 1D3 (right panel). The staining of primary antibody was detected with FITC-conjugated goat anti-rat Ig (Cat. No. 554016). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Two-color analysis of the expression of CD19 on mouse spleen B cells. BALB/c splenocytes were simultaneously stained with PE-conjugated mouse anti-mouse IgM[a] mAb DS-1 (Cat. No. 553517) and either purified rat IgG2a, κ isotype control mAb R35-95 (Cat. No. 553927, left panel) or purified rat anti-mouse CD19 mAb 1D3 (right panel). The staining of primary antibody was detected with FITC-conjugated goat anti-rat Ig (Cat. No. 554016). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Two-color analysis of the expression of CD19 on mouse spleen B cells. BALB/c splenocytes were simultaneously stained with PE-conjugated mouse anti-mouse IgM[a] mAb DS-1 (Cat. No. 553517) and either purified rat IgG2a, κ isotype control mAb R35-95 (Cat. No. 553927, left panel) or purified rat anti-mouse CD19 mAb 1D3 (right panel). The staining of primary antibody was detected with FITC-conjugated goat anti-rat Ig (Cat. No. 554016). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Two-color analysis of the expression of CD19 on mouse spleen B cells. BALB/c splenocytes were simultaneously stained with PE-conjugated mouse anti-mouse IgM[a] mAb DS-1 (Cat. No. 553517) and either purified rat IgG2a, κ isotype control mAb R35-95 (Cat. No. 553927, left panel) or purified rat anti-mouse CD19 mAb 1D3 (right panel). The staining of primary antibody was detected with FITC-conjugated goat anti-rat Ig (Cat. No. 554016). Flow cytometry was performed on a BD FACScan™ flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 1D3 antibody reacts with CD19, a B lymphocyte-lineage differentiation antigen. CD19, a 95-kDa transmembrance glycoprotein, is a member of the immunoglobulin superfamily and is expressed throughout B-lymphocyte development from the pro-B cell through the mature B-cell stages. Terminally differentiated plasma cells do not express CD19. On the surface of mature B cells, the CD19 molecule associates with CD21 (CR-2) and CD81 (TAPA-1), and this multimolecular complex synergizes with surface immunoglobulin to promote cellular activation. Studies with CD19-deficient mice have suggested that the level of CD19 expression affects the generation and maturation of B cells in the bone marrow and periphery. B-1 lineage B cells, also known as CD5+ B cells, are drastically reduced or absent in CD19-deficient mice. Increased levels of CD19 expression correlate with increased frequencies of peritonal and splenic B-1 cells and reduced numbers of conventional B lymphocytes in the periphery. CD19 participates in B-lymphocyte development, B-cell activation, maturation of memory B cells and regulation of tolerance. CD19 has also been detected on peritoneal mast cells, co-localized with CD21/CD35, and it is proposed to play a role in complement-mediated mast-cell activation.
This antibody is routinely tested by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.